Dose-escalation using intensity-modulated radiotherapy for prostate cancer - evaluation of quality of life with and without 18F-choline PET-CT detected simultaneous integrated boost

Open Access

30 January 2012

journal article
research article
Published by Springer Nature in Radiation Oncology

Vol. 7 (1) , 14
https://doi.org/10.1186/1748-717x-7-14

Abstract

In comparison to the conventional whole-prostate dose escalation, an integrated boost to the macroscopic malignant lesion might potentially improve tumor control rates without increasing toxicity. Quality of life after radiotherapy (RT) with vs. without 18F-choline PET-CT detected simultaneous integrated boost (SIB) was prospectively evaluated in this study.

Keywords

This publication has 24 references indexed in Scilit:

Consequential late effects after radiotherapy for prostate cancer - a prospective longitudinal quality of life study
Radiation Oncology, 2010
Dose-escalation using intensity-modulated radiotherapy for prostate cancer – Evaluation of the dose distribution with and without 18F-choline PET-CT detected simultaneous integrated boost
Radiotherapy and Oncology, 2009
Self-assessed bowel toxicity after external beam radiotherapy for prostate cancer - predictive factors on irritative symptoms, incontinence and rectal bleeding
Radiation Oncology, 2009
Detection of Aggressive Primary Prostate Cancer with ¹¹C-Choline PET/CT Using Multimodality Fusion Techniques
Journal of Nuclear Medicine, 2009
Higher-Than-Conventional Radiation Doses in Localized Prostate Cancer Treatment: A Meta-analysis of Randomized, Controlled Trials
International Journal of Radiation Oncology*Biology*Physics, 2009
Molecular imaging of prostate cancer
Methods, 2009
Factor Analysis of the Expanded Prostate Cancer Index Composite in a Patient Group after Primary (External Beam Radiotherapy and Permanent Iodine-125 Brachytherapy) and Postoperative Radiotherapy for Prostate Cancer
Current Urology, 2009
Intensity-Modulated Radiotherapy as Primary Therapy for Prostate Cancer: Report on Acute Toxicity After Dose Escalation With Simultaneous Integrated Boost to Intraprostatic Lesion
International Journal of Radiation Oncology*Biology*Physics, 2008
Evaluation of [¹¹C]‐choline positron‐emission/computed tomography in patients with increasing prostate‐specific antigen levels after primary treatment for prostate cancer
BJU International, 2007
Impact of a Higher Radiation Dose on Local Control and Survival in Breast-Conserving Therapy of Early Breast Cancer: 10-Year Results of the Randomized Boost Versus No Boost EORTC 22881-10882 Trial
Journal of Clinical Oncology, 2007